POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 42 | / | 2017 | ||||||||
Date of issue: | 2017-09-29 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Acquisition of treasury shares | |||||||||||
Official market - legal basis | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
With a reference to the public notice from 28 July 2017, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 22 September 2017 up to and including 28 September 2017. Krka acquired 6,952 treasury shares in the total value of EUR 386,985 on the Ljubljana Stock Exchange as follows: - on 22 September: 541 shares at a weighted average price of EUR 55.16, - on 26 September: 1,956 shares at a weighted average price of EUR 55.44, - on 27 September: 2,084 shares at a weighted average price of EUR 55.68 and - on 28 September: 2,371 shares at a weighted average price of EUR 55.95. SKB d.d. and NLB d.d. were brokers in these transactions. The total number of treasury shares prior to these transactions was 631,890 representing 1.927% of all shares issued. The total number of treasury shares after these transactions is 638,842 representing 1.948% of all shares issued. | |||||||||||
Annexes | |||||||||||
File | Description |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2017-09-29 | Jože Colarič | President of the Management Board |